NICE has developed medical technology guidance on the E-vita open plus.
NICE medical technologies guidance addresses specific technologies notified to NICE by manufacturers. The ‘case for adoption’ recommendations are based on the claimed advantages of introducing the specific technology compared with current management of the condition. This ‘case’ is reviewed against the evidence submitted and expert advice. If the case for adopting the technology is supported, then the technology has been found to offer advantages to patients and the NHS. The specific recommendations on individual technologies are not intended to limit use of other relevant technologies which may offer similar advantages.
NICE has said that the E-vita open plus can be used for some people, depending on the type of operation they need. Hospital teams may want to use the E-vita open plus because it could avoid the need for a second operation, and could save money in the long term (around 2 years after the procedure).